Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.71 |
| ▸ | LPL | P06858 | 10/20 | 0.71 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.62 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
| ▸ | P4HB | P07237 | 1/20 | 0.40 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18015662 | 0.93 | DGAT1 (0.70) | LIPGLPLDGAT1HPGDSP4HB | |
| SCHEMBL15747808 | 0.91 | DGAT1 (0.69) | LIPGLPLDGAT1HPGDSP4HB | |
| SCHEMBL29688361 | 0.89 | DGAT1 (0.70) | LIPGLPLDGAT1P4HBPDGFRB | |
| SCHEMBL30739 | 0.89 | DGAT1 (0.70) | LIPGLPLDGAT1P4HBPDGFRB | |
| SCHEMBL19794477 | 0.89 | LIPG (0.59) | LIPGLPLDGAT1HPGDSP4HB | |
| SCHEMBL19106594 | 0.89 | LIPG (0.59) | LIPGLPLDGAT1HPGDSP4HB | |
| SCHEMBL19106625 | 0.88 | LIPG (0.58) | LIPGLPLDGAT1P4HBPDGFRB | |
| SCHEMBL19794486 | 0.88 | LIPG (0.57) | LIPGLPLDGAT1P4HBPDGFRB | |
| SCHEMBL23105561 | 0.87 | DGAT1 (0.55) | LIPGLPLDGAT1HPGDSPDGFRB | |
| SCHEMBL29412555 | 0.87 | LIPG (0.56) | LIPGLPLDGAT1HPGDSPDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | OR10J3, ORMDL3, OR51E2 | LIPG 548/4885LPL 218/4885DGAT1 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.